NathanN,SullivanSD, 2014.The utility of metformin therapy in reproductive aged women with Polycystic Ovary Syndrome (PCOS),Curr Pharm Biotechnol 15 70 -83
EhrmannDA,LongoDA,FauciAS,KasperD, 2012.Hirsutism and virilization,Harrisons's Principles of Medicine, 18th Edn 380 4 -
RahnamaZ,SohbatiS,SafizadehH, 2013.Effect of hirsutism on quality of life: A study in Iranian women,J Pak Assoc Derma 23 28 -33
SahinSB,YucelAF,BedirR,OgullarS,AyazT,AlgunE, 2014.Testosterone and cortisol-secreting adrenocortical oncocytoma: An unusual cause of hirsutism,Case Rep Endocrinol 206890 -
RamezaniTF,MinooeeS, 2014.Validation of a simplified method to assess hirsutism in the Iranian population,Eur J Obstet Gynecol Reprod Biol 174 91 -5
EsmaeilzadehS,AndariehMG,GhadimiR,DelavarMA, 2015.Body Mass Index and Gonadotropin Hormones (LH & FSH) Associate With clinical symptoms among women with polycystic ovary syndrome,Glob J Health Sci 7 101 -106
FranksS., 2012.The investigation and management of hirsutism,J Fam Plan Reprod Health Care 38 182 -6
YacoubSE, 2011.Reduction of diameter of hair shaft among women with hirsutism,Global J Health 3 135 -41
JyotiAB,BhosleD,KadamR, 2014.Comparison of efficacy and safety of metformin, oral contraceptive combination of ethinyl estradiol and drospirenone alone or in combination in polycystic ovarian syndrome,J Obes Metab Res 2 112 -7
GanieMA,KhuranaML,NisarS,ShahPA,ShahZA,KulshresthaB, 2013.Improved efficacy of low-dose spironolactone and metformin combination than either drug alone in the management of women with polycystic ovary syndrome (PCOS): A six-month open-label randomized study,J Clin Endocrinol Metab 98 3599 -607
EhrmannDA, 2005.Polycystic ovary syndrome,N Engl J Med 352 1223 -36
LoboRA,ShoupeD,SerafiniP,BrintonD,HortonR., 1985.The effects of two doses of spironolactone on serum androgens and anagen hair in hirsute women,Fertil Steril 43 200 -205
SpritzerPM,LisboaKO,MattielloS, 2000.Spironolactone as a single agent for long-term therapy of hirsute patients,Clin Endocrinol (Oxf) 52 587 -94
LegroR,ArslanianSA,EhrmannDA,HoegerKM,MuradMH,PasqualiR, 2013.Diagnosis and treatment of polycystic ovary syndrome: An endocrine society clinical practice guideline,J Clin Endocrinol Metab 98 4565 -92
KellyCJ,GordonD., 2002.The effect of metformin on hirsutism in polycystic ovary syndrome,Eur J Endocrinol 147 217 -21
DiriH,KaraburguS,AcmazB,UnluhizarciK,TanriverdiF,KaracaZ, 2016.Comparison of spironolactone and spironolactone plus metformin in the treatment of polycystic ovary syndrome,Gynecol Endocrinol 32 42 -5
OnerG,MuderrisII, 2011.A prospective randomized trial comparing low dose ethinyl estradiol and drospirenone 24/4 combined oral contraceptive vs. ethinyl estradiol and drospirenone 21/7 combined oral contraceptive in the treatment of hirstutism,Contraception 84 508 -11
LeelaphiwatS,JongwutiwesT,LertvikoolS,TabcharoenC,SukprasertM,RattanasiriS,WeerakietS., 2015.Comparison of desogestrel/ethinyl estradiol plus spironolactone versus cyproterone acetate/ethinyl estradiol in the treatment of polycystic ovary syndrome: A randomized controlled trial,J Obstet Gynaecol Res 41 402 -10
El MaghrabyHA,NafeeT,GuiziryD,ElnasharA, 2015.Randomized controlled trial of the effects of metformin versus combined oral contraceptives in adolescent PCOS women through a 24 month follow up period,Middle East Fertil Soc J 21 131 -7